High-throughput phosphotyrosine profiling using SH2 domains.
暂无分享,去创建一个
Tony Pawson | Dong-Guk Shin | Martin R Schiller | Peter Nollau | Kazuya Machida | Kevin Dierck | Bruce J Mayer | T. Pawson | M. Schiller | B. Mayer | P. Nash | S. Kärkkäinen | K. Saksela | Dong-Guk Shin | Bernard A. Liu | K. Jablonowski | D. Newman | Christopher M Thompson | G. Renkema | Debra K Newman | K. Machida | Kalle Saksela | Bernard Liu | Satu Kärkkäinen | G Herma Renkema | Piers D Nash | Karl Jablonowski | Haimin Zhang | P. Nollau | Haimin Zhang | ChristopherM. Thompson | K. Dierck | Piers Nash
[1] Forest M. White,et al. Modeling HER2 Effects on Cell Behavior from Mass Spectrometry Phosphotyrosine Data , 2006, PLoS Comput. Biol..
[2] M. Mann,et al. Global, In Vivo, and Site-Specific Phosphorylation Dynamics in Signaling Networks , 2006, Cell.
[3] B. Mayer,et al. Quantitative multiplexed profiling of cellular signaling networks using phosphotyrosine-specific DNA-tagged SH2 domains , 2006, Nature Methods.
[4] T. Pawson,et al. The human and mouse complement of SH2 domain proteins-establishing the boundaries of phosphotyrosine signaling. , 2006, Molecular cell.
[5] Xianqiang L Li,et al. Src Homology 2 Domain-based High Throughput Assays for Profiling Downstream Molecules in Receptor Tyrosine Kinase Pathways*S , 2006, Molecular & Cellular Proteomics.
[6] R. Norton,et al. The structure of SOCS3 reveals the basis of the extended SH2 domain function and identifies an unstructured insertion that regulates stability. , 2006, Molecular cell.
[7] William A. McLaughlin,et al. Prediction of binding sites of peptide recognition domains: an application on Grb2 and SAP SH2 domains. , 2006, Journal of molecular biology.
[8] Gavin MacBeath,et al. A quantitative protein interaction network for the ErbB receptors using protein microarrays , 2006, Nature.
[9] Forest M White,et al. Global phosphoproteome of HT-29 human colon adenocarcinoma cells. , 2005, Journal of proteome research.
[10] S. Hubbard,et al. Structural Characterization of a Novel Cbl Phosphotyrosine Recognition Motif in the APS Family of Adapter Proteins* , 2005, Journal of Biological Chemistry.
[11] Kazuya Machida,et al. The SH2 domain: versatile signaling module and pharmaceutical target. , 2005, Biochimica et biophysica acta.
[12] Sompop Bencharit,et al. Structural and evolutionary division of phosphotyrosine binding (PTB) domains. , 2005, Journal of molecular biology.
[13] Bruce Tidor,et al. A computational method for the analysis and prediction of protein:phosphopeptide‐binding sites , 2005, Protein science : a publication of the Protein Society.
[14] Alok J. Saldanha,et al. Java Treeview - extensible visualization of microarray data , 2004, Bioinform..
[15] Paul J Utz,et al. Protein microarrays for multiplex analysis of signal transduction pathways , 2004, Nature Medicine.
[16] Tony Pawson,et al. Specificity in Signal Transduction From Phosphotyrosine-SH2 Domain Interactions to Complex Cellular Systems , 2004, Cell.
[17] Guido Tarone,et al. Positional control of cell fate through joint integrin/receptor protein kinase signaling. , 2003, Annual review of cell and developmental biology.
[18] G. Bokoch. Biology of the p21-activated kinases. , 2003, Annual review of biochemistry.
[19] N. Mahajan,et al. An SH2 Domain-dependent, Phosphotyrosine-independent Interaction between Vav1 and the Mer Receptor Tyrosine Kinase , 2003, Journal of Biological Chemistry.
[20] P. Newman,et al. Signal transduction pathways mediated by PECAM-1: new roles for an old molecule in platelet and vascular cell biology. , 2003, Arteriosclerosis, thrombosis, and vascular biology.
[21] B. Mayer,et al. Profiling the Global Tyrosine Phosphorylation State* , 2003, Molecular & Cellular Proteomics.
[22] Emanuel F Petricoin,et al. Protein microarrays: meeting analytical challenges for clinical applications. , 2003, Cancer cell.
[23] Blagoy Blagoev,et al. A proteomics strategy to elucidate functional protein-protein interactions applied to EGF signaling , 2003, Nature Biotechnology.
[24] Gavin MacBeath,et al. Protein microarrays and proteomics , 2002, Nature Genetics.
[25] K. Saksela,et al. Cdc42/Rac1-Mediated Activation Primes PAK2 for Superactivation by Tyrosine Phosphorylation , 2002, Molecular and Cellular Biology.
[26] D. Krag,et al. Identification of Novel Non-phosphorylated Ligands, Which Bind Selectively to the SH2 Domain of Grb7* , 2002, The Journal of Biological Chemistry.
[27] M. Yaffe. Phosphotyrosine-binding domains in signal transduction , 2002, Nature Reviews Molecular Cell Biology.
[28] Tony Pawson,et al. A ‘three‐pronged’ binding mechanism for the SAP/SH2D1A SH2 domain: structural basis and relevance to the XLP syndrome , 2002, The EMBO journal.
[29] T Pawson,et al. SH2 domains, interaction modules and cellular wiring. , 2001, Trends in cell biology.
[30] B. Mayer,et al. Profiling the global tyrosine phosphorylation state by Src homology 2 domain binding , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[31] E. Petricoin,et al. Reverse phase protein microarrays which capture disease progression show activation of pro-survival pathways at the cancer invasion front , 2001, Oncogene.
[32] T. Hunter,et al. Signaling—2000 and Beyond , 2000, Cell.
[33] T. Pawson,et al. Novel mode of ligand binding by the SH2 domain of the human XLP disease gene product SAP/SH2D1A , 1999, Current Biology.
[34] C Terhorst,et al. Crystal structures of the XLP protein SAP reveal a class of SH2 domains with extended, phosphotyrosine-independent sequence recognition. , 1999, Molecular cell.
[35] J. Lord,et al. Differential association of cytoplasmic signalling molecules SHP‐1, SHP‐2, SHIP and phospholipase C‐γ1 with PECAM‐1/CD31 , 1999, FEBS letters.
[36] D. Botstein,et al. Cluster analysis and display of genome-wide expression patterns. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[37] D. Allen,et al. The X-linked lymphoproliferative-disease gene product SAP regulates signals induced through the co-receptor SLAM , 1998, Nature.
[38] R. Sakai,et al. Evidence that SH2 domains promote processive phosphorylation by protein-tyrosine kinases , 1995, Current Biology.
[39] J. Wang,et al. Src homology 2 domain as a specificity determinant in the c-Abl-mediated tyrosine phosphorylation of the RNA polymerase II carboxyl-terminal repeated domain. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[40] Charis Eng,et al. Catalytic specificity of protein-tyrosine kinases is critical for selective signalling , 1995, Nature.
[41] R. Croll,et al. Western blotting of formaldehyde-fixed neuropeptides as small as 400 daltons on gelatin-coated nitrocellulose paper. , 1994, Analytical biochemistry.
[42] T. Pawson,et al. Nuclear magnetic resonance structure of an SH2 domain of phospholipase C-γ1 complexed with a high affinity binding peptide , 1994, Cell.
[43] H. Hanafusa,et al. Analysis of the binding of the Src homology 2 domain of Csk to tyrosine-phosphorylated proteins in the suppression and mitotic activation of c-Src. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[44] T. Pawson,et al. SH2 domains recognize specific phosphopeptide sequences , 1993, Cell.
[45] D. Baltimore,et al. The noncatalytic src homology region 2 segment of abl tyrosine kinase binds to tyrosine-phosphorylated cellular proteins with high affinity. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[46] B. Sefton,et al. Most of the substrates of oncogenic viral tyrosine protein kinases can be phosphorylated by cellular tyrosine protein kinases in normal cells. , 1988, Oncogene research.
[47] T Pawson,et al. A noncatalytic domain conserved among cytoplasmic protein-tyrosine kinases modifies the kinase function and transforming activity of Fujinami sarcoma virus P130gag-fps , 1986, Molecular and cellular biology.
[48] D Cowburn,et al. Modular peptide recognition domains in eukaryotic signaling. , 1997, Annual review of biophysics and biomolecular structure.